Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression-Reference-Cited by-同舟云学术

Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression

Published:2021-01 Issue:1 Volume:14 Page:100883
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Vitorino Philip,Chuang Chen-Hua,Iannello Alexandre,Zhao Xi,Anderson Wade,Ferrando Ronald,Zhang Zhaomei,Madhavan Shravanthi,Karsunky Holger,Saunders Laura R.

Funder

AbbVie

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Comprehensive genomic profiles of small cell lung cancer;George;Nature,2015

2. Notch signaling induces cell cycle arrest in small cell lung cancer cells;Sriuranpong;Cancer Res.,2001

3. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers;Augustyn;Proc. Natl. Acad. Sci. U. S. A.,2014

4. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer;Jiang;Cancer Res.,2009

5. A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo;Saunders;Sci Transl Med,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CMG901, a Claudin18.2-specific antibody-drug conjugate, for the treatment of solid tumors;Cell Reports Medicine;2024-09

2. Expression patterns and clinical implications of PDL1 and DLL3 biomarkers in small cell lung cancer retrospectively studied: Insights for therapeutic strategies and survival prediction;Heliyon;2024-03

3. Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer;Virchows Archiv;2024-02-13

4. Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates;Cancers;2023-11-10

5. Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma;Human Pathology;2023-11